ClinicalTrials.gov
public full text
Public Domain
Study of Antidepressants in Parkinson's Disease
The purpose of this study is to find out if two antidepressant medications, paroxetine and venlafaxine, can help control depression in Parkinson's disease, and if these medications affect the motor symptoms of Parkinson's disease such as tremor, stiffness, slowness, and balance.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives#935861
- Tolerability, Safety and Efficacy of Vortioxetine#1125453
- Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression#800591
- Dopamine Effect on Inhibitory Control#1152832
- Vergleich einer Parkinson-Kohorte mit einer Nicht-Parkinson-Kohorte hinsichtlich psychosozialer und körperlicher Auswirkungen der COVID-19-Pandemie / Lisa-Marie Chidex ; Gutachter: Thomas Bahmer ; Betreuer: Walter Mätzler#664605
Record · ID 870228
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive